CONCERT: A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-Blind Twelve-Month Safety and Efficacy Study evaluating Dimebon in Patients with Mild-to-moderate Alzheimer Disease on Donepezil (2009–2011)
- Grant type:
- Novotech (Australia) Pty Ltd
- Researchers:
-
-
Mayne Professor of Psychiatry
Medical School (Office & AME)Faculty of Medicine
-
- Funded by:
- Novotech (Australia) Pty Ltd
